Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arbaclofen Placarbil MTD in Alcohol Use Disorder
NCT02511886Phase 2Completed
- Sponsor
- Indivior
- Start
- Sep 2015
- Primary completion
- Jan 2016
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of arbaclofen placarbil in alcohol use disorder (AUD), sponsored by Indivior. Started Sep 2015; status: completed.
02
Drugs
arbaclofen placarbil
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT02511886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02511886.